Oracle announced Monday the purchase of Micros Systems for $5.3B, or $68 per share. Oracle plans to combine Micros' industry-specific applications with its own business software. Not only that, Oracle says the deal will immediately add to its adjusted earnings. Meanwhile, shares of Vertex Pharmaceuticals soared more than 40% Tuesday after the drugmaker said its cystic fibrosis treatment worked better than a placebo in a late-stage study. Cystic fibrosis is a rare inherited disease that causes thick mucus to form in the lungs. Finally, the Commerce Department gave Pioneer Natural Resources and Enterprise Products Partners permission to ship a type of ultralight oil to foreign buyers. The shipments will be America's first oil exports in nearly 40 years.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Video
Cramer's Takeaways for Ford, Chevron, Alibaba, Biogen, Visa
Cramer breaks down what investors need to takeaway from Chevron CVX and Ford F and explains why he's betting on a win from the Beardstown Ladies in CNBC's annual stock draft. The team picked Alibaba BABA , Biogen BIIB and Visa V.
Can Avengers: Endgame Crush These Marvel Box Office Records?
Avengers: Endgame is flexing its muscle and plowing towards another box office record. But, will it surpass its Marvel counterparts? Watch the video for some movie trivia.
Watch: Jim Cramer Analyzes VZ, WMT, XOM, AXP, BA, LUV, CVX, GS, HD In Real Time
Have you ever seen someone analyze the 'tape' in real time? See Jim Cramer give his real time stock analysis on companies like Home Depot, Goldman Sachs, IBM, Verizon and more.
Jim Cramer Responds to Elon Musk, Talks Intel, Chevron, Ford and More
Need a road map to close out this week on Wall Street? Jim Cramer breaks down everything investors need to know about the markets from Chevron to Intel.
Jim Cramer Says Intel Investors Should Keep This One Thing In Mind
Intel's shares tumble after its outlook for the second quarter and year is well shy of forecasts. Here's Jim Cramer's takeaway for Intel investors.